Organigram (TSE:OGI) Given a C$3.00 Price Target by Canaccord Genuity Group Analysts

Organigram (TSE:OGI) received a C$3.00 price target from Canaccord Genuity Group in a research report issued on Tuesday, Marketbeat Ratings reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group’s price target points to a potential upside of 38.89% from the stock’s previous close.

Organigram Stock Down 3.1%

OGI opened at C$2.16 on Tuesday. The company has a 50 day moving average of C$2.34 and a 200 day moving average of C$2.30. The company has a market cap of C$290.44 million, a PE ratio of -11.13, a price-to-earnings-growth ratio of 0.42 and a beta of 2.11. Organigram has a 12 month low of C$1.22 and a 12 month high of C$3.09. The company has a current ratio of 3.36, a quick ratio of 2.62 and a debt-to-equity ratio of 3.07.

About Organigram

Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.